1 / 54

Basic Clinician Training Module 3

Basic Clinician Training Module 3. Basic bleeding profiles. Introduction to bleeding. Causes of bleeding Mechanical – vascular injury Pathophysiological – imbalance between the anticoagulant/antithrombotic and prothrombotic forces of the hemostatic system

tracy
Download Presentation

Basic Clinician Training Module 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Basic Clinician TrainingModule 3 Basic bleeding profiles

  2. Introduction to bleeding • Causes of bleeding • Mechanical – vascular injury • Pathophysiological – imbalance between the anticoagulant/antithrombotic and prothrombotic forces of the hemostatic system • Monitoring hemostasis – finding where the imbalance resides

  3. Monitoring bleeding with the TEG • TEG analysis – monitoring hemostatic components and their interactions. • Mechanical – Normal TEG parameters • Pathophysiological • R: enzymatic pathway abnormality • Angle (a): fibrinogen deficiency • MA: platelet abnormality • LY30: fibrinolysis (See Module 6)

  4. Decision Tree EPL > 15% No or Yes LY30 > 7.5% C.I. Hemorrhage C.I. > 3.0 No Yes < 1.0 > 3.0 R > 10min R < 3min No Yes Primary fibrinolysis Secondary fibrinolysis No Yes Fibrinolysis Low clotting factors Platelet hypercoagulability MA > 73mm MA < 55mm No Yes Yes No Low platelet function Enzymatic hypercoagulability Enzymatic & platelet hypercoagulability a < 45º i Yes Hypercoagulable Low fibrinogen level

  5. Mechanical bleeding • Characterized by bleeding patient with a normal TEG tracing. • Probable cause: Surgical injury to blood vessel with insufficient repair of the blood vessel. • Other possible explanations • Clot development not confined to injury site – suggests vWF deficiency • Presence of platelet inhibitors

  6. Patient status: bleeding • Probable cause (3): • Vessel injury • vWF deficiency • Presence of platelet inhibitor

  7. Patient status: bleeding • Probable cause  Common treatment: • Vessel injury  Suture • vWF deficiency  DDAVP • Presence of platelet inhibitor  Run Platelet Mapping

  8. Enzymatic pathway abnormalities • Characterized by a bleeding patient and a TEG tracing with an abnormally long R value. • Factor deficiency may also cause abnormalities in other TEG parameters (angle, MA) • Probable causes: • Coagulation factor(s) deficiency • Coagulation factor dysfunction • Presence of anticoagulant (i.e. residual heparin) • Effect: • Slow rate of thrombin generation leading to slow clot development • Insufficient thrombin generation leading to insufficient clot development

  9. Causes of enzymatic pathway abnormalities • Coagulation factor deficiency • Hemodilution • Liver disease or liver congestion • Trauma with significant blood loss and/or blood salvage • Congenital – i.e. hemophilia • Factor consumption > synthesis • Cardiopulmonary bypass, ECMO • Disseminated intravascular coagulation (DIC) • Coagulation factor dysfunction • Vitamin K deficiency • Warfarin treatment • Presence of anticoagulant • Residual heparin

  10. Enzymatic pathway abnormality:Coagulation factor deficiency Patient status: bleeding Patient condition: bleeding Probable cause: factor deficiency Probable cause: Factor deficiency

  11. Enzymatic pathway abnormality:Coagulation factor deficiency Patient status: bleeding • Probable cause(s): • Factor deficiency • Platelet deficiency/dysfunction

  12. Enzymatic pathway abnormality:Coagulation factor deficiency Patient status: bleeding • Probable cause(s)  Common treatment(s) • Factor deficiency  FFP • Platelet deficiency/dysfunction  platelets

  13. Enzymatic pathway abnormality:Residual heparin • Characterized by a bleeding patient and a TEG tracing with an abnormally long R value (non-heparinase sample) • Probable causes: • Residual heparin after protamine administration due to insufficient protamine dose. • Heparin rebound – reappearance of heparin in circulation after initial reversal with protamine • Release of endogenous sources of heparin (i.e. reperfusion of transplanted liver) • Effect: inhibition of thrombin action resulting in reduced fibrin formation and clot development.

  14. Enzymatic pathway abnormality:Residual heparin Post Protamine Patient status: Bleeding • Probable cause(s): • Residual heparin • Factor deficiency First TEST for residual heparin

  15. Testing for residual heparin with the TEG analyzer • Run blood sample on two channels simultaneously • K = kaolin activated (clear cup) • KH = kaolin with heparinase (blue cup) • Results: • If R for K  KH, long R is not due to heparin • If R for K is long and for KH is normal, heparin is present in blood sample

  16. Testing for residual heparin with the TEG analyzer R for K > KH suggests presence of heparin

  17. Fibrinogen deficiency • Characterized by a bleeding patient and a TEG tracing with only an abnormally low angle (a). • Probable cause: low fibrinogen levels • Effect: slow rate of clot development • Note: The angle parameter is influenced by the enzymatic and platelet pathways, thus correcting a deficiency or defect in these pathways will typically correct the angle.

  18. Causes of fibrinogen deficiency • Liver disease or congestion • Disseminated intravascular coagulation (DIC) – hypocoagulable stage • OB-GYN complications – placental abruption • Hemodilution • Excessive consumption

  19. Fibrinogen deficiency Patient status: bleeding Probable cause: fibrinogen deficiency

  20. Fibrinogen deficiency Patient status: Bleeding Probable cause: Fibrinogen deficiency Common treatment: Cryoprecipitate or FFP

  21. Platelet abnormality • Characterized by a bleeding patient and a TEG tracing with an abnormally low MA value • A low MA value may also be associated with an elongated R and/or a low angle values • Probable causes: • Low platelet number • Low platelet function • Note: The TEG cannot distinguish between a low platelet count and low platelet function • Effect: formation of a clot with low clot strength that is insufficient to stop vascular bleeding.

  22. Platelet abnormality:A note on low platelet counts • In certain disease states platelet counts may be reduced, but the remaining platelets may be hyperfunctional and hypersensitive, resulting in normal or high clot strength (normal to high MA). • Example: cancer patients

  23. Platelet abnormalityLow platelet counts - causes • Bone marrow disorders (i.e. leukemia) • Chemotherapy • Congenital disorder • Lupus • Trauma with significant blood loss and/or blood salvage • Hemodilution • Cardiac valve dysfunction – regurgitation • Consumption and/or sequestration • Platelet antibodies - HITT

  24. Platelet abnormalityPlatelet dysfunction - Mechanisms • Activation – inhibition or dysfunction of platelet receptors • Adhesion – inhibition or dysfunction of GPIb receptor preventing adhesion of platelet to endothelium • Aggregation – inhibition or dysfunction of GPIIb/IIIa receptors preventing the development of a platelet plug • Secretion – inhibition or dysfunction of secretory pathways resulting in reduced platelet activation • Procoagulant activity – reduction of thrombin generation on platelet surface

  25. Platelet abnormalityLow platelet function - causes • Cardiopulmonary bypass • Antiplatelet therapies • Platelet antibodies • Congenital disorders • Liver disease • Uremia • Consumption

  26. Platelet abnormality Patient status: bleeding • Probable cause(s): • Low platelet count +/or • Low platelet function

  27. Platelet abnormality Patient status: bleeding • Probable cause(s)  Common treatments: • Low platelet count  platelet transfusion • Low platelet function  platelet transfusion

  28. Platelet abnormality Patient status: bleeding • Probable cause(s): • Low platelet count +/or • Low platelet function

  29. Platelet abnormality Patient status: bleeding • Probable cause(s)  Common treatment • Low platelet count  platelet transfusion • Low platelet function  platelet transfusion

  30. Platelet abnormality Patient status: bleeding • Probable cause(s): • Factor deficiency +/or • Low platelet count +/or • Low platelet function

  31. Platelet abnormality Patient status: bleeding • Probable cause(s)  Common treatment(s): • Factor deficiency  FFP +/or • Low platelet count  platelet transfusion • Low platelet function  platelet transfusion

  32. Platelet abnormalitiesSpecial considerations • The inhibition of platelets by platelet inhibitors may not be revealed by the TEG using a kaolin activated sample. This is due to thrombin generation in the blood sample which results in maximum activation of platelets which overrides other activation pathways. • An important factor to consider in induced platelet dysfunction (i.e., treatment with antiplatelet drugs) is the monitoring of platelet inhibition. • PlateletMapping™ assays measure the degree of inhibition at the ADP receptor and arachadonic acid pathways as well as provide a reference point against which to interpret the inhibition (See Module 6)

  33. Interpretation Exercises Hemorrhage

  34. Exercise 1 Black tracing: Kaolin Green tracing: Kaolin with heparinase • Using the TEG Decision Tree, what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Normal • Has heparin been reversed in this patient? Yes or No. Answer Next

  35. Exercise 2 Post-protamine Patient status: bleeding • Using the TEG Decision Tree, what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Normal • What treatment(s) would you consider for this patient? Answer Next

  36. Exercise 3 Patient status: Bleeding • Using the TEG Decision Tree and the available information from the TEG tracing: • Is it likely the patient will require more protamine as a treatment for bleeding? Yes or No. • Is it likely the patient will require FFP as a treatment for bleeding? Yes or No. Next Answer

  37. Exercise 4 Patient status: Bleeding • Using the TEG Decision Tree what is a likely cause(s) of bleeding in this patient? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Surgical bleeding • What treatment(s) would you consider for this patient? Answer Next

  38. Exercise 5 • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Normal • If this patient was bleeding, what treatment(s) would you consider? Answer Next

  39. Exercise 6 Post-protamine Patient status: bleeding • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Anticoagulant effect • Platelet deficiency or dysfunction • Low fibrinogen level • Surgical bleeding • What treatment(s) would you consider for this patient? Answer Next

  40. Exercise 7 Black tracing: Kaolin Green tracing: Kaolin with heparinase Patient status: bleeding • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Anticoagulant effect • Platelet deficiency or dysfunction • Low fibrinogen level • Surgical bleeding • How would you treat this patient? Answer Next

  41. Exercise 8 Post-protamine • - The above patient is bleeding after administration of protamine. What are the possible • causes of bleeding (select all that apply)? • - For each selection, identify one treatment consideration. • Surgical bleeding • Factor deficiency • Residual platelet inhibitor effect • Diminished platelet adhesion • Anticoagulant effect Answer Next

  42. Exercise 9 • The above is the baseline TEG (post-induction) of a female patient (70 yr, 54kg) requiring • CABG with CPB. The patient has not been taking aspirin for 7 days (81 mg/d). • Based on this TEG and the patient history, is this patient at risk for bleeding post-CPB? Yes or No. • If so, what will be the most likely cause(s) of bleeding? • Surgical bleeding • Factor deficiency • Platelet deficiency/dysfunction • Fibrinolysis • Anticoagulant effect Answer Next

  43. Exercise 10 Green: Post-protamine Black: ICU • The above patient has started bleeding approximately 1 hr post-op. What is the most likely • cause(s) of bleeding? • Surgical bleeding • Factor deficiency • Platelet deficiency/dysfunction • Fibrinolysis • Anticoagulant effect • How would you treat this patient? Answer END

  44. Exercise 1 Black tracing: Kaolin Green tracing: Kaolin with heparinase • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Normal – all parameters are within normal range • Has heparin been reversed in this patient?Yes or No. Since the R values for both • the kaolin and kaolin with heparinase samples are the same suggests that the • heparin has been reversed. Back

  45. Exercise 2 Post-protamine Patient status: bleeding • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Normal • What treatment(s) would you consider for this patient? After completion of protamine • administration, consider treating with platelets first. Repeat TEG. If R value is still • elongated and the patient is bleeding, consider treating with FFP. Back

  46. Exercise 3 Patient status: Bleeding • Using the TEG Decision Tree and the available information from the TEG tracing: • Is it likely the patient will require more protamine as a treatment for bleeding? Yes or No. • This is a tracing from a kaolin activated sample. The presence of heparin in a kaolin sample • would result in an elongated R value. An R within normal range suggests heparin is not present, • thus additional protamine is not required. • Is it likely the patient will require FFP as a treatment for bleeding? Yes or No. • An R value within normal range suggests that factor deficiency is not the cause • of bleeding in this patient. Back

  47. Exercise 4 Patient status: Bleeding • Using the TEG Decision Tree what is a likely cause(s) of bleeding in this patient? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Surgical bleeding • A slightly elongated R may suggest factor deficiency, however surgical bleeding cannot • be ruled out. • What treatment(s) would you consider for this patient? The R value is less than the • trigger point for FFP transfusion. If patient is oozing, wait an hour and repeat the • TEG. If R is still elongated and the patient is still oozy, consider treating with FFP. Back

  48. Exercise 5 • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Platelet deficiency or dysfunction • Low fibrinogen level • Fibrinolysis • Normal • If this patient was bleeding, what treatment(s) would you consider? • Cryoprecipitate or FFP Back

  49. Exercise 6 Post-protamine Patient status: bleeding • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency • Anticoagulant effect • Platelet deficiency or dysfunction • Low fibrinogen level • Surgical bleeding • What treatment(s) would you consider for this patient? Platelet transfusion Back

  50. Exercise 7 Black tracing: Kaolin Green tracing: Kaolin with heparinase Patient status: bleeding • Using the TEG Decision Tree what is your interpretation of this TEG tracing? • [Select all that apply] • Factor deficiency (cannot rule out) • Anticoagulant effect (incomplete reversal of heparin) • Platelet deficiency or dysfunction (cannot rule out) • Low fibrinogen level • Surgical bleeding • How would you treat this patient? A common treatment protocol would likely • include administration of additional protamine to reverse the heparin effect. • If the patient continues to bleed, repeat the TEG to determine the probable • cause. Most likely platelet deficiency/dysfunction. Back

More Related